Language
Hengrui Pharmaceuticals Is Said to Weigh Second Listing in Hong Kong - Bloomberg

News

HomeHome / News / Hengrui Pharmaceuticals Is Said to Weigh Second Listing in Hong Kong - Bloomberg
search
RECENT NEWS

Jun 21, 2023

Odyssey Marine Exploration Announces Partnership with Ocean Minerals LLC for a New Cook Islands Exploration Project

Aug 01, 2023

Analysis of the impact of DGAT1 p.M435L and p.K232A variants on pre

Sep 06, 2023

Could ultra

Oct 10, 2023

Sunrise Group among the world's top ten chemical distributors

Oct 14, 2023

Orally Disintegrating Tablet Excipient Market Research Report 2023

SEND YOUR INQUIRY
SUBMIT

Oct 23, 2024

Hengrui Pharmaceuticals Is Said to Weigh Second Listing in Hong Kong - Bloomberg

The headquarters of Jiangsu Hengrui Pharmaceuticals Co. in Jiangsu Province. Jiangsu Hengrui Pharmaceuticals Co. is considering a second listing in Hong Kong that could happen as soon as next year,

The headquarters of Jiangsu Hengrui Pharmaceuticals Co. in Jiangsu Province.

Jiangsu Hengrui Pharmaceuticals Co. is considering a second listing in Hong Kong that could happen as soon as next year, according to people familiar with the situation.

The company is in talks with advisers about the potential share sale, which might raise at least $2 billion, the people said, asking not to be identified as the information is private.